To help reach the objectives of the Coronavirus Global Response, EUR 1 billion will be mobilised under the EU’s flagship programme for research and innovation, Horizon 2020.
The EUR 1 billion from Horizon 2020 can be broken down in:
EUR 450 million for developing scientific solutions for testing, treating and preventing against the coronavirus and developing health systems
EUR 400 million EC guarantee of the European Investment Bank lending to finance pre- commercial stage investments in COVID-19 research and development (including scale up of production facilities)
EUR 150 million for disruptive innovations on COVID-19 under the European Innovation Council’s Accelerator
BACKGROUND
The Commission has been launching several specific Research and Innovation (R&I) actions through Horizon 2020 since the beginning of the current crisis. These actions address epidemiology, preparedness and response to outbreaks, the development of diagnostics, treatments and vaccines, as well as the infrastructures and resources that enable these R&I activities. In order to accelerate the development of vaccines, new treatments, diagnostic tests and reinforce medical systems in the fight against the coronavirus, it is important to further step up the mobilisation of funds under Horizon 2020 in order to contribute to the Global Response pledging marathon launched on 4 May 2020.The table below gives a complete overview of all allocated and planned funding available under Horizon 2020 to contribute to the Coronavirus Global Response pledging marathon. In total, EUR 1 billion is pledged under Horizon 2020.
Since January 2020 a total of EUR 352 million has already been mobilised under Horizon 2020.